Skip to main content

Galderma Supply Update 20.05.2021

Dear Valued Customer,

Azzalure quota policy has been updated; the quotas have been refreshed from today - this means that customers whom previously ordered and have reached their quota limit will be able to re-order from today. The quota limits are as per below:

The quota limit per customer account is 4 x 125 Speywood unit vials of Azzalure.
Quota limit in place on Azzalure Speywood unit vials has been refreshed from 20th May 2021 until further notice and is subject to change based on stock levels.

How can we help you?

Delivering a trusted medical aesthetics service for almost 15 years

Thriving on customer satisfaction, Church Pharmacy has been delivering a trusted pharmacy service to the medical aesthetics sector for over 10 years. We are not a big corporate company that prioritise profits, we have always believed customer loyalty is earned from looking after our customers first. Given the regretful stock issues with Azzalure, we would welcome feedback from you about how this may be impacting you – please share your thoughts by contacting us. As always, we are here to listen, adapt and improve for our valued customers, so that we can be more helpful and useful to you for your clinic needs.

Please note: We have only been experiencing supply issues with Azzalure (Botulinum Toxin type A). We do not have any supply issues with any other Botulinum Toxin type A products such as Bocouture and Botox. If you would like more information on these products or any other product we are listing on our website please contact us and we will do our best to help support your clinic needs while making savings for you during this difficult and unprecedented time.

For our latest product and service offerings please click here.

For any training enquiries or product support queries please feel free to contact us on

Thank you

The Church Pharmacy Team

Contact us

About the author

Church Pharmacy

Cookie Policy

Church Pharmacy uses cookies to improve your browsing experience. If you continue, we'll assume that you are happy to receive cookies from our website, although you can change your browser's cookie settings at any time. Find out more.


Back to top